Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Return on Equity (2016 - 2025)

IGC Pharma (IGC) has disclosed Return on Equity for 15 consecutive years, with 0.91% as the latest value for Q3 2025.

  • Quarterly Return on Equity rose 74.0% to 0.91% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.91% through Sep 2025, up 74.0% year-over-year, with the annual reading at 1.04% for FY2025, 13.0% up from the prior year.
  • Return on Equity for Q3 2025 was 0.91% at IGC Pharma, up from 1.02% in the prior quarter.
  • The five-year high for Return on Equity was 0.27% in Q2 2021, with the low at 1.75% in Q2 2024.
  • Average Return on Equity over 5 years is 0.88%, with a median of 0.77% recorded in 2023.
  • The sharpest move saw Return on Equity plummeted -98bps in 2024, then surged 74bps in 2025.
  • Over 5 years, Return on Equity stood at 0.38% in 2021, then crashed by -93bps to 0.73% in 2022, then crashed by -68bps to 1.22% in 2023, then fell by -6bps to 1.29% in 2024, then increased by 30bps to 0.91% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.91%, 1.02%, and 1.13% for Q3 2025, Q2 2025, and Q1 2025 respectively.